Chill Brands
Chill Brands · page 2
- Markets & Stocks
Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] LSE-listed Celadon Pharmaceuticals announced that it had signed a new commercial sales contract set to be worth £1.2m with an unnamed UK pharmaceutical company.
- Markets & Stocks
MGC Pharma Announces New A$2.7m Share Purchase Plan, Chill Brands Revenues Drop 87%, & Hellenic Receives EU Grant
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals released a flurry of updates over the last week, announcing plans to launch a A$2.7m share purchase plan for its Australian investors, just weeks after conditionally raising a further £700,000.
- Markets & Stocks
Chill Brands Sees Stock Climb 80% On New UK Supply Deal, IM Cannabis Reduces Losses, & Celadon Signs First Supply Contract
Chill Brands Group [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CHLL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Chill Brands’ stock value has nearly doubled over the last week following the announcement of a new sales and distribution partnership in the UK.
- Companies
European Cannabis Stocks Review: Intercure Breaks Israeli Records In 2022, Chill Brands Rises, & Akanda Could Face Delisting Again
InterCure [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”INCR” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] InterCure has continued its blistering run of financial performance after revealing another record quarter over the weekend, ‘solidifying (its) leading position’ over its Israeli competitors and sending its stock up over 20%.
- Markets & Stocks
European Cannabis Stocks Review: DeepVerge Drops 60% As It Warns May Not Have ‘Sufficient Equity’ To Make Loan Repayments
WHILE last week’s news from the US saw many EU cannabis stocks experience a spike in stock price on Friday, these gains were almost unanimously lost within hours.
- Pharmaceutical
Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses
AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies released their latest financial figures.
- News
European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos
FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE), the market chaos caused by the UK Chancellor’s ‘mini budget’ has wiped £22,328,775 from the collective market value of LSE-listed cannabis stocks.
- Markets & Stocks
European Cannabis Stocks Review: Chill Brands Becomes Latest UK-Listed Stock To Stage Comeback, IM Cannabis Edges Closer To Delisting, & More From Cellular Goods
THIS week has seen European cannabis stocks once again gain momentum in the face of dismal economic news.
- Adult-Use
European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill Brands
It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making progress on cannabis liberalisation.
- News
Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain
CHILL Brands’ shareholders have voted in favour of plans for a new £3.5m fundraise alongside a separate £484,000 open share offer to ‘ensure the company is well capitalised and able to grow’.
- Markets & Stocks
EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC Pharma
LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine.
- Press releases
Cellular Goods Launches Rejuvenating Cannabinoid Face Serum
Cellular Goods’ Cannabinoid Face Serum is the UK’s first cannabigerol (CBG)-powered serum, which works to prevent the signs of aging caused by UV-light exposure and inflammation.
